{
    "id": 15664,
    "fullName": "NUAK2 amp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "NUAK2 amp indicates an increased number of copies of the NUAK2 gene. However, the mechanism causing the increase is unspecified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 81788,
        "geneSymbol": "NUAK2",
        "terms": [
            "NUAK2",
            "SNARK"
        ]
    },
    "variant": "amp",
    "createDate": "12/23/2015",
    "updateDate": "11/29/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 3799,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Roscovotine (seliciclib) inhibited proliferation of melanoma cells with concurrent NUAK2 amplification and PTEN loss in culture and in cell line xenograft models, with increased efficacy when compared to response in cells with either NUAK2 amplification or PTEN loss alone (PMID: 25832654).",
            "molecularProfile": {
                "id": 15934,
                "profileName": "NUAK2 amp PTEN loss"
            },
            "therapy": {
                "id": 1129,
                "therapyName": "Seliciclib",
                "synonyms": null
            },
            "indication": {
                "id": 8923,
                "name": "skin melanoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 4165,
                    "pubMedId": 25832654,
                    "title": "NUAK2 Amplification Coupled with PTEN Deficiency Promotes Melanoma Development via CDK Activation.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25832654"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 15932,
            "profileName": "NUAK2 amp",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 15934,
            "profileName": "NUAK2 amp PTEN loss",
            "profileTreatmentApproaches": [
                {
                    "id": 7238,
                    "name": "Seliciclib",
                    "profileName": "NUAK2 amp PTEN loss"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}